Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 86.00
Bid: 84.00
Ask: 88.00
Change: 0.00 (0.00%)
Spread: 4.00 (4.762%)
Open: 86.00
High: 86.00
Low: 86.00
Prev. Close: 86.00
CRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Letter re Valmont Offer for Delta plc

22 Mar 2010 07:00

19 March 2010 CRYSTAL AMBER FUND LIMITED ("Crystal Amber Fund" or the "Company") Letter re. Valmont Group Pty Ltd offer for Delta plc

Crystal Amber Fund announces that it is going to request that the directors of Delta plc send a copy of a letter from the directors of Crystal Amber Fund, the text of which is set out below, to all shareholders of Delta plc as soon as possible, at the Company's expense. In addition, the letter will be available on the Company's website www.crystalamber.com.

" Dear fellow Delta plc shareholder,

Crystal Amber Fund Limited ("Crystal Amber") was a shareholder in Delta plc ("Delta") prior to the announcement on 4 March 2010 of the 185p per share recommended offer from Valmont Group Pty. Ltd (`Valmont') ("the Offer"). We invested in Delta because we regarded it as a well managed, profitable, cash rich British engineering group. We currently hold 5,803,533 ordinary shares in Delta, representing 3.77 per cent. of the issued share capital of Delta.

It is our intention not to accept the current offer of 185p ("the Offer Price"), unless the Offer is declared or becomes wholly unconditional, on the basis that, in our opinion, it undervalues the business and, as currently constructed, is neither fair nor reasonable.

Delta shareholders will note that the offer document issued by Valmont dated 10 March ("the Offer Document") states at pages 7 and 12 that "the Offer Price has been determined on the basis that no final dividend in respect of the ordinary share capital of Delta will be paid by Delta in respect of the year ended 31 December 2009". Furthermore, both Valmont and the directors of Delta state in the Offer Document (pages 7 and 12) that:

"The Offer Price represents a premium of approximately:

. 20.3 per cent. to the closing price of 153.8 pence for each Delta Share on 3 March 2010, the latest practicable Business Day prior to the date of this announcement;

. 24.7 per cent. to the average closing price of 148.4 pence for each Delta Share for the month prior to and including 3 March 2010; and

. 27.3 per cent. to the average closing price of 145.3 pence for each Delta Share for the three months prior to and including 3 March 2010."

Delta Shareholders will be aware that for the year ended 31 December 2008, Delta declared dividends of an aggregate of 6.5p per share and the interim dividend for the six months ended 30 June 2009, declared on 28 August 2009, of 2.4p per share was an increase of 26 per cent. over the interim dividend declared for the six months ended 30 June 2008. Market consensus estimates were that the final dividend for the year ended 31 December 2009 would be 4.8p, resulting in a dividend of 7.2p per share for the full year (Source: Arden Partners /Arbuthnot Securities).

We believe that, by basing the Offer Price on the cancellation of the final dividend, the Offer Price includes an element of 4.8p that might otherwise have formed the final dividend for the year ended 31 December 2009. Consequently, the price that shareholders are being offered to cede control of Delta is effectively 180.2p, which is only a premium of 17.2 per cent. to the closing price of 153.8 pence for each Delta Share on 3 March 2010, the latest practicable business day prior to the date of the announcement of the Offer.

In this context, we also note that the preliminary results for the year ended 31 December 2009, announced on 8 March 2010, delivered earnings per share for the year ended 31 December 2009 of 20.2p, approximately 13.9 per cent. ahead of broker consensus forecasts of 17.735p (Source: Arden Partners /Arbuthnot Securities). In the post close trading update issued by Delta on 26 January 2010 the directors stated that "The Group's 2009 full year trading performance was in line with the Board's expectations". We are unclear as to why the Board's expectations were so materially different to those of the market and wonder what effect this improved trading would have had on the Delta share price if the broker consensus forecasts had reflected the improved trading.

We also note that since the Offer was announced on 4 March 2010, the share price of Valmont ordinary shares has increased from $73.44 (at close of business on 3 March 2010) to $83.32 (at close of business on 18 March 2010), an increase of 13.4 per cent, which, in our opinion, strongly implies that the market believes that Valmont is offering a low price for Delta and that Valmont shareholders will be the beneficiaries of this proposed takeover. In the period since the announcement of the Offer up until the close of business on 18 March 2010, the stock market capitalisation of Valmont has increased by in excess of $259 million, or £173 million at an exchange rate of £1:$1.50. This compares with the value of the Valmont Offer for the entire issued share capital of Delta of £284.5 million, with Delta's consolidated net cash at 31 December 2009 being £146.9 million.

We believe that the Offer Price should be increased so that Delta's shareholders are compensated properly for, in our opinion, the significant value enhancement that Valmont shareholders seem set to receive if the Offer is successful. We also consider it neither fair nor reasonable that Delta shareholders have not been afforded the opportunity to participate in the equity upside of the proposed combined businesses and believe that a share alternative should be made available to Delta shareholders based on the Valmont share price of $73.44 at the close of business on 3 March 2010, being the latest practicable business day prior to the announcement of the Offer.

We consider that the Offer undervalues Delta and intend NOT to accept the current offer by Valmont, unless the Offer is declared or becomes wholly unconditional.

Yours sincerely,William CollinsChairmanCrystal Amber Fund Limited"

For further enquiries please contact:

Crystal Amber Advisers (UK) LLP - Investment adviser to Crystal Amber Fund

Richard Bernstein

Tel: 020 7491 0770

Merchant John East Securities Limited

David Worlidge/Bidhi Bhoma

Tel: 0207 628 2200

vendor
Date   Source Headline
28th Jun 20245:15 pmRNSTotal Voting Rights
21st Jun 20245:00 pmRNSTransaction in Own Shares and Total Voting Rights
19th Jun 202410:07 amRNSMonthly Net Asset Value
18th Jun 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jun 20244:49 pmRNSTransaction in Own Shares and Total Voting Rights
6th Jun 20245:15 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jun 20245:43 pmRNSTransaction in Own Shares and Total Voting Rights
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNSMorphic Medical – FDA approval of study amendments
3rd Jun 20245:33 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 20245:39 pmRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
23rd May 20241:21 pmRNSMonthly Net Asset Value
23rd May 20247:00 amRNSExtension to Share Buyback Programme
22nd May 20247:00 amRNSTransaction in Own Shares
17th May 20245:49 pmRNSTransaction in Own Shares
3rd May 20246:22 pmRNSHolding(s) in Company
2nd May 202412:37 pmRNSHolding(s) in Company
1st May 20245:22 pmRNSTransaction in Own Shares
30th Apr 20245:37 pmRNSTotal Voting Rights
29th Apr 20243:26 pmRNSHolding(s) in Company
26th Apr 20245:27 pmRNSTransaction in Own Shares
25th Apr 20247:00 amRNSHolding(s) in Company
24th Apr 20244:00 pmRNSMonthly Net Asset Value
24th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20246:22 pmRNSTransaction in Own Shares
10th Apr 20249:34 amRNSTransaction in Own Shares
3rd Apr 20244:44 pmRNSMonthly Net Asset Value
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:30 pmRNSExtension to Share Buyback Programme
28th Mar 20246:01 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSHalf-year Report
27th Mar 20246:27 pmRNSTransaction in Own Shares
22nd Mar 20245:09 pmRNSTransaction in Own Shares
18th Mar 20245:29 pmRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20245:30 pmRNSTransaction in Own Shares
11th Mar 20244:59 pmRNSTransaction in Own Shares
7th Mar 20245:38 pmRNSTransaction in Own Shares
29th Feb 20245:30 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSNotice of Interim Results and Portfolio Update
27th Feb 20247:00 amRNSDirector/PDMR Dealing
26th Feb 20244:45 pmRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20246:02 pmRNSTransaction in Own Shares
22nd Feb 20249:28 amRNSMonthly Net Asset Value
22nd Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.